Fig. 1From: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groupsOverall survival from the surgery in “CRS plus HIPEC” and “CRS only” groupsBack to article page